Urology Research & Practice

Staging of Prostate Cancer: Role of Multiparametric Magnetic Resonance Imaging in Different Risk Classes


Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Foggia, Italy


Radiology Hospital “Carlo Urbani”, Jesi, Italy


Diagnostic Imaging, Clinical and Interventional Radiology, IRCCS INRCA, Ancona, Italy


Radiology Unit, “Dimiccoli” Hospital, Barletta, Italy.


Department of Radiology, Hospital IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy

Urol Res Pract 2023; 49: 216-224
DOI: 10.5152/tud.2023.22261
Read: 1215 Downloads: 533 Published: 01 July 2023

Using multiparametric magnetic resonance imaging, it is now possible to diagnose prostate cancer and categorize its risk. As it can accurately determine the extracapsu- lar extension of the tumor, invasion of seminal vesicles, involvement of lymph nodes, and the potential presence of bone metastases, multiparametric magnetic resonance imaging plays a crucial role not only in the diagnosis but also in the local staging of prostate cancer. The patients with a history of negative biopsy/increasing prostate- specific antigen and the existence of further data supporting its use in biopsy-naive patients and active surveillance are the most blatant indications for multiparametric magnetic resonance imaging in guidelines. The traditional clinical examination, pros- tate-specific antigen tests, and systematic biopsy are all enhanced by multiparametric magnetic resonance imaging, which will miss certain cancers due to insufficient size or changes in tissue density. The use of multiparametric magnetic resonance imaging is expected to rise, and further advances in the method will be crucial for the secure adoption of targeted therapeutic ideas. Here, we give a succinct overview of multipa- rametric magnetic resonance imaging's application to the identification and risk clas- sification of prostate cancer.

Cite this article as: Saverio Guerra F, Eusebi L, Bartelli F, Cecchini S, Paci E, Guglielmi G. Staging of prostate cancer: Role of multiparametric magnetic resonance imaging in different risk classes. Urol Res Pract. 2023;49(4):216-224

EISSN 2980-1478